In the case of associated clinical features suggesting a syndromic presentation such as MEN1, FAP or HLRCC, a complementary genotyping of MEN1, APC or FH genes should be considered [1]. This evidence concerns the gene MEN1 and hereditary leiomyomatosis and renal cell cancer.